advertisement

Oculus

11.3.3 Apraclonidine, brimonidine (7)

Showing records 1 to 7

Display all abstracts in classification 11.3.3 Apraclonidine, brimonidine

Search within classification 11.3.3 Apraclonidine, brimonidine
82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Duru Z
Cutaneous and Ocular Toxicology 2020; 39: 21-24
82619 Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model
Zhou X
Experimental Eye Research 2019; 189: 107833
82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Hwang HB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511
82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Ozsaygili C
Cutaneous and Ocular Toxicology 2020; 39: 21-24
82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Kim SY
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511
82619 Brimonidine enhances inhibitory postsynaptic activity of OFF- and ON-type retinal ganglion cells in a Wistar rat chronic glaucoma model
Zhang T; Wu J
Experimental Eye Research 2019; 189: 107833
82141 Histopathologic Analysis of Conjunctival Lymphoproliferative Disease After Topical Brimonidine Use
Ohn K
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 503-511

Issue 20-4

Select Issue


advertisement

WGC-2021